PVT1 and nonpapillary renal cell carcinoma: Since PVT1 can act as an important oncogenic driver in many cancers, and it may also help identify ccRCC patients as serum biomarker, we are eager to figure out whether it can play important roles in the carcinogenesis of ccRCC and why it can exert regulatory functions in ccRCC.